« Open-Source Pharmaceutical Babble |
| Let's Just Spread This Deal Out All Over the Paper, Why Don't We? »
July 29, 2010
New from OSI / Astellas
When last we heard about the takeover of OSI by Astellas, everyone was standing around wondering what was going to happen. Some of that uncertainly seems, unfortunately, to be vanishing. A source tells me that the OSI people have been informed that their Ardsley headquarters and the Melville site on Long Island are to close. The fate of the Farmingdale site on LI is still unclear. Ardsley used to be where Purdue Pharma had a lot of people, and I don't think that OSI has been there that long, actually.
I've also heard that development staff at OSI have been told that they're being let go, but are free to re-apply to Astellas - that could mean several things, none of them particularly good, but that's all I have so far.
+ TrackBacks (0) | Category: Business and Markets
POST A COMMENT
- RELATED ENTRIES
- XKCD on Protein Folding
- The 2014 Chemistry Nobel: Beating the Diffraction Limit
- German Pharma, Or What's Left of It
- Sunesis Fails with Vosaroxin
- A New Way to Estimate a Compound's Chances?
- Meinwald Honored
- Molecular Biology Turns Into Chemistry
- Speaking at Northeastern